News Celgene files AML pill after fast-track trial The FDA has accepted Celgene’s filing for enasidenib.
News Novartis drug gets fast US review in AML Midostaurin also under review in rare disease systemic mastocytosis
Partner Content Partner Content Positive PIII results for VYXEOS revealed at ASCO Building on the announcement made in March of this year, Celator Pharmaceuticals has today (June 4th) presented the Phase III (PIII) findings for its combination therapy VYXEOS (cytarabine and daun
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
